Latest News about RPRX
Recent news which mentions RPRX
From Benzinga
From Benzinga
From Benzinga
The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout
February 18, 2021
From Benzinga
Here's What Caused Royalty Pharma's Mixed Results in Q4
February 17, 2021
From Motley Fool
Repros Therapeutics (RPRX) Q4 2020 Earnings Call Transcript
February 17, 2021
Tickers
RPRX
From Motley Fool
Earnings Scheduled For February 17, 2021
February 17, 2021
From Benzinga
The Week Ahead In Biotech: FDA Decision On G1 Therapeutics, Earnings In The Mix For Light Calendar Week
February 14, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
December 24, 2020
From Benzinga
2 Ultra-High-Growth Healthcare Stocks That Are Just Getting Started
December 23, 2020
From Motley Fool
4 Reasons Agios' Oncology Deal Should Please Investors
December 22, 2020
From Motley Fool
The Daily Biotech Pulse: ASH Presentations, Axsome's Positive Midstage Readout, Follow-On Offerings
December 08, 2020
From Benzinga
Earnings Scheduled For November 11, 2020
November 11, 2020
From Benzinga
The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions
November 08, 2020
From Benzinga
46 Stocks Moving In Monday's Mid-Day Session
November 02, 2020
From Benzinga
The Daily Biotech Pulse: Novavax Vaccine Data, Axovant Flags Delay In Parkinson's Study, 2 Biotechs Make Wall Street Debuts
October 30, 2020
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
October 29, 2020
From Benzinga
The Daily Biotech Pulse: Novartis Acquires Gene Therapy Company, Moderna's Japanese Vaccine Supply Deal
October 29, 2020
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
October 28, 2020
From Benzinga
The Daily Biotech Pulse: Sanofi-GlaxoSmithKline To Supply 200M Doses To COVID-19 Vaccine Alliance, Gilead Earnings, Biodesix Debuts
October 28, 2020
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
October 27, 2020
From Benzinga
Cramer Weighs In On Corsair, Marvell And More
October 23, 2020
From Benzinga
The Daily Biotech Pulse: FDA Vaccine Committee Meeting, Roche In $350M Deal for COVID-19 Treatment, Edwards Lifesciences Reports Q3 Beat
October 22, 2020
From Benzinga
10 Stocks Moving In Tuesday's After-Hours Session
October 13, 2020
From Benzinga
12 Healthcare Stocks Moving In Tuesday's After-Market Session
October 13, 2020
From Benzinga
Cramer Shares His Thoughts On Boeing, General Electric And More
September 28, 2020
From Benzinga
The Daily Biotech Pulse: AstraZeneca Pauses Coronavirus Vaccine Study, Trillium To Get $25M Pfizer Investment
September 09, 2020
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
September 08, 2020
From Benzinga
Stocks That Hit 52-Week Lows On Friday
September 04, 2020
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.